Neovasc Stock Price, News & Analysis
Company Description
Neovasc (NASDAQ: NVCN) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $83.6M.
NVCN stock has gained 216.1% over the past year.
This page provides a comprehensive overview of NVCN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Neovasc (NVCN) stock. Over the past 12 months, the stock has gained 216.1%. At a market capitalization of $83.6M, NVCN is classified as a micro-cap stock with approximately 2.8M shares outstanding.
Latest News
Neovasc has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, earnings, clinical trial, conferences. View all NVCN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
NVCN Company Profile & Sector Positioning
Neovasc (NVCN) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing NVCN often look at related companies in the same sector, including Xtant Medical (XTNT), Baird Medical (BDMD), Apyx Medical Corporation (APYX), Inspiremd (NSPR), and Pulmonx Corp (LUNG). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NVCN's relative position within its industry.